Phar­mas ral­ly to pro­tect em­ploy­ees in Ukraine, along with sup­port and do­na­tions to Rus­sia-in­vad­ed coun­try

As the bio­phar­ma in­dus­try mon­i­tors drug de­vel­op­ment and sup­ply dis­rup­tions that might stem from the Russ­ian in­va­sion of Ukraine, in­di­vid­ual phar­ma com­pa­nies are work­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER